Apellis Pharmaceuticals Inc. (APLS)
Market Closed
15 May, 20:00
$
41. 03
0
0%
$
5.25B Market Cap
- P/E Ratio
- Div Yield
28,642,670 Volume
-4.51 Eps
$ 41.03
Previous Close 
Want to track APLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Apellis Pharmaceuticals Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JCB John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH | 6,977 | $175,262.27 | $286,266.31 | $111,004.04 | 63.34% |
| EPI Evelyn Partners Investment Management LLP Evelyn Partners Investment Management LLP | 150 | $3,280.5 | $6,154.5 | $2,874 | 87.61% |
| NR Nicole Reese WPG Advisers LLC | 5 | $160 | $205.15 | $45.15 | 28.22% |
| UFP United Financial Planning Group LLC United Financial Planning Group LLC | 24 | $603 | $984.72 | $381.72 | 63.3% |
| JB Jon Borer Capitolis Liquid Global Markets LLC | 1.01M | $40.77M | $41.58M | $810,800 | 1.99% |
